Vaccination of children (Taken from the internet)
(CRHoy.com) The National Commission for Vaccination and Epidemiology (CNVE) It analyzes extending the age for the indication to place the bivalent vaccine against COVID-19 that the country acquired.
“In upcoming sessions of the CNVE, the issue of the bivalent vaccine and its use in the age group of less than 12 years will be discussed; As soon as an agreement is reached in this regard, it will be communicated through official channels”, reported the CNVE through the institutional email before the consultation on the subject.
It should be remembered that last November, the technical committee agreed on the acquisition of this type of dose to use it as a reinforcement among those over 12 years of age, two months after the last vaccination received.
On January 19, the members of the decentralized collegiate body of the Ministry of Health, decided to advance the entry of these bivalent vaccines, this with the aim of having greater availability for those who want to apply the reinforcement against COVID-19.
“Therefore, the vaccines that would go in for the third and fourth trimesters will now go in for the first and second trimesters. In total, the country would have 507,400 vaccines for the first two quarters of this year,” the Ministry of Health detailed.
bivalent vaccines
Bivalent vaccines against SARS-COV-2 are those that contain two different types of antigens; one of the original COVID-19 strain that emerged in Wuhan, China; and another of the omicron BA variant.1., provocative of the most recent pandemic waves, along with its sublineages.
However, each note that the United States Food and Drug Administration (FDA) authorities explained that these do not replace the original doses in their previous first, second, third, and fourth dose placements. to the bivalent
